Home > > > Report Detail

Global Oncology (Anti-cancer Drugs) Market Research Report 2023

Publisher Name :
Date: 16-Mar-2023
No. of pages: 91
Inquire Before Buying

Highlights

The global Oncology (Anti-cancer Drugs) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Oncology (Anti-cancer Drugs) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Oncology (Anti-cancer Drugs) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Oncology (Anti-cancer Drugs) include Roche, Novartis, Celgene, Amgen, Johnson & Johnson, GlaxoSmithKline, Eli lilly & Co, Pfizer and Merck & Co., etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncology (Anti-cancer Drugs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology (Anti-cancer Drugs).

The Oncology (Anti-cancer Drugs) market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oncology (Anti-cancer Drugs) market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oncology (Anti-cancer Drugs) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Roche

- Novartis

- Celgene

- Amgen

- Johnson & Johnson

- GlaxoSmithKline

- Eli lilly & Co

- Pfizer

- Merck & Co.

- Sanofi

Segment by Type

- Blood Cancer

- Breast Cancer

- Gastrointestinal Cancer

- Prostate Cancer

- Others

Segment by Application

- Chemotherapy

- Targeted Therapy

- Immunotherapy (Biologic Therapy)

- Hormonal Therapy

- Others

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Oncology (Anti-cancer Drugs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Oncology (Anti-cancer Drugs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Oncology (Anti-cancer Drugs) Market Research Report 2023

Table of Contents
1 Oncology (Anti-cancer Drugs) Market Overview
1.1 Product Overview and Scope of Oncology (Anti-cancer Drugs)
1.2 Oncology (Anti-cancer Drugs) Segment by Type
1.2.1 Global Oncology (Anti-cancer Drugs) Market Value Comparison by Type (2023-2029)
1.2.2 Blood Cancer
1.2.3 Breast Cancer
1.2.4 Gastrointestinal Cancer
1.2.5 Prostate Cancer
1.2.6 Others
1.3 Oncology (Anti-cancer Drugs) Segment by Application
1.3.1 Global Oncology (Anti-cancer Drugs) Market Value by Application: (2023-2029)
1.3.2 Chemotherapy
1.3.3 Targeted Therapy
1.3.4 Immunotherapy (Biologic Therapy)
1.3.5 Hormonal Therapy
1.3.6 Others
1.4 Global Oncology (Anti-cancer Drugs) Market Size Estimates and Forecasts
1.4.1 Global Oncology (Anti-cancer Drugs) Revenue 2018-2029
1.4.2 Global Oncology (Anti-cancer Drugs) Sales 2018-2029
1.4.3 Global Oncology (Anti-cancer Drugs) Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Oncology (Anti-cancer Drugs) Market Competition by Manufacturers
2.1 Global Oncology (Anti-cancer Drugs) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Oncology (Anti-cancer Drugs) Average Price by Manufacturers (2018-2023)
2.4 Global Oncology (Anti-cancer Drugs) Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Oncology (Anti-cancer Drugs), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oncology (Anti-cancer Drugs), Product Type & Application
2.7 Oncology (Anti-cancer Drugs) Market Competitive Situation and Trends
2.7.1 Oncology (Anti-cancer Drugs) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oncology (Anti-cancer Drugs) Players Market Share by Revenue
2.7.3 Global Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oncology (Anti-cancer Drugs) Retrospective Market Scenario by Region
3.1 Global Oncology (Anti-cancer Drugs) Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Oncology (Anti-cancer Drugs) Global Oncology (Anti-cancer Drugs) Sales by Region: 2018-2029
3.2.1 Global Oncology (Anti-cancer Drugs) Sales by Region: 2018-2023
3.2.2 Global Oncology (Anti-cancer Drugs) Sales by Region: 2024-2029
3.3 Global Oncology (Anti-cancer Drugs) Global Oncology (Anti-cancer Drugs) Revenue by Region: 2018-2029
3.3.1 Global Oncology (Anti-cancer Drugs) Revenue by Region: 2018-2023
3.3.2 Global Oncology (Anti-cancer Drugs) Revenue by Region: 2024-2029
3.4 North America Oncology (Anti-cancer Drugs) Market Facts & Figures by Country
3.4.1 North America Oncology (Anti-cancer Drugs) Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Oncology (Anti-cancer Drugs) Sales by Country (2018-2029)
3.4.3 North America Oncology (Anti-cancer Drugs) Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oncology (Anti-cancer Drugs) Market Facts & Figures by Country
3.5.1 Europe Oncology (Anti-cancer Drugs) Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Oncology (Anti-cancer Drugs) Sales by Country (2018-2029)
3.5.3 Europe Oncology (Anti-cancer Drugs) Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oncology (Anti-cancer Drugs) Market Facts & Figures by Country
3.6.1 Asia Pacific Oncology (Anti-cancer Drugs) Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Oncology (Anti-cancer Drugs) Sales by Country (2018-2029)
3.6.3 Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oncology (Anti-cancer Drugs) Market Facts & Figures by Country
3.7.1 Latin America Oncology (Anti-cancer Drugs) Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Oncology (Anti-cancer Drugs) Sales by Country (2018-2029)
3.7.3 Latin America Oncology (Anti-cancer Drugs) Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oncology (Anti-cancer Drugs) Market Facts & Figures by Country
3.8.1 Middle East and Africa Oncology (Anti-cancer Drugs) Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2018-2029)
3.8.3 Middle East and Africa Oncology (Anti-cancer Drugs) Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oncology (Anti-cancer Drugs) Sales by Type (2018-2029)
4.1.1 Global Oncology (Anti-cancer Drugs) Sales by Type (2018-2023)
4.1.2 Global Oncology (Anti-cancer Drugs) Sales by Type (2024-2029)
4.1.3 Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2018-2029)
4.2 Global Oncology (Anti-cancer Drugs) Revenue by Type (2018-2029)
4.2.1 Global Oncology (Anti-cancer Drugs) Revenue by Type (2018-2023)
4.2.2 Global Oncology (Anti-cancer Drugs) Revenue by Type (2024-2029)
4.2.3 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2018-2029)
4.3 Global Oncology (Anti-cancer Drugs) Price by Type (2018-2029)
5 Segment by Application
5.1 Global Oncology (Anti-cancer Drugs) Sales by Application (2018-2029)
5.1.1 Global Oncology (Anti-cancer Drugs) Sales by Application (2018-2023)
5.1.2 Global Oncology (Anti-cancer Drugs) Sales by Application (2024-2029)
5.1.3 Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2018-2029)
5.2 Global Oncology (Anti-cancer Drugs) Revenue by Application (2018-2029)
5.2.1 Global Oncology (Anti-cancer Drugs) Revenue by Application (2018-2023)
5.2.2 Global Oncology (Anti-cancer Drugs) Revenue by Application (2024-2029)
5.2.3 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2018-2029)
5.3 Global Oncology (Anti-cancer Drugs) Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Oncology (Anti-cancer Drugs) Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis Oncology (Anti-cancer Drugs) Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Celgene
6.3.1 Celgene Corporation Information
6.3.2 Celgene Description and Business Overview
6.3.3 Celgene Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Celgene Oncology (Anti-cancer Drugs) Product Portfolio
6.3.5 Celgene Recent Developments/Updates
6.4 Amgen
6.4.1 Amgen Corporation Information
6.4.2 Amgen Description and Business Overview
6.4.3 Amgen Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Amgen Oncology (Anti-cancer Drugs) Product Portfolio
6.4.5 Amgen Recent Developments/Updates
6.5 Johnson & Johnson
6.5.1 Johnson & Johnson Corporation Information
6.5.2 Johnson & Johnson Description and Business Overview
6.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Johnson & Johnson Oncology (Anti-cancer Drugs) Product Portfolio
6.5.5 Johnson & Johnson Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
6.6.4 GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Eli lilly & Co
6.6.1 Eli lilly & Co Corporation Information
6.6.2 Eli lilly & Co Description and Business Overview
6.6.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Eli lilly & Co Oncology (Anti-cancer Drugs) Product Portfolio
6.7.5 Eli lilly & Co Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Pfizer Oncology (Anti-cancer Drugs) Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Merck & Co.
6.9.1 Merck & Co. Corporation Information
6.9.2 Merck & Co. Description and Business Overview
6.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Merck & Co. Oncology (Anti-cancer Drugs) Product Portfolio
6.9.5 Merck & Co. Recent Developments/Updates
6.10 Sanofi
6.10.1 Sanofi Corporation Information
6.10.2 Sanofi Description and Business Overview
6.10.3 Sanofi Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sanofi Oncology (Anti-cancer Drugs) Product Portfolio
6.10.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oncology (Anti-cancer Drugs) Industry Chain Analysis
7.2 Oncology (Anti-cancer Drugs) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oncology (Anti-cancer Drugs) Production Mode & Process
7.4 Oncology (Anti-cancer Drugs) Sales and Marketing
7.4.1 Oncology (Anti-cancer Drugs) Sales Channels
7.4.2 Oncology (Anti-cancer Drugs) Distributors
7.5 Oncology (Anti-cancer Drugs) Customers
8 Oncology (Anti-cancer Drugs) Market Dynamics
8.1 Oncology (Anti-cancer Drugs) Industry Trends
8.2 Oncology (Anti-cancer Drugs) Market Drivers
8.3 Oncology (Anti-cancer Drugs) Market Challenges
8.4 Oncology (Anti-cancer Drugs) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Oncology (Anti-cancer Drugs) Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Oncology (Anti-cancer Drugs) Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Oncology (Anti-cancer Drugs) Market Competitive Situation by Manufacturers in 2022
Table 4. Global Oncology (Anti-cancer Drugs) Sales (K MT) of Key Manufacturers (2018-2023)
Table 5. Global Oncology (Anti-cancer Drugs) Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Oncology (Anti-cancer Drugs) Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Oncology (Anti-cancer Drugs) Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Oncology (Anti-cancer Drugs) Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Oncology (Anti-cancer Drugs), Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Oncology (Anti-cancer Drugs), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oncology (Anti-cancer Drugs), Product Type & Application
Table 12. Global Key Manufacturers of Oncology (Anti-cancer Drugs), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oncology (Anti-cancer Drugs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology (Anti-cancer Drugs) as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oncology (Anti-cancer Drugs) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Oncology (Anti-cancer Drugs) Sales by Region (2018-2023) & (K MT)
Table 18. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2018-2023)
Table 19. Global Oncology (Anti-cancer Drugs) Sales by Region (2024-2029) & (K MT)
Table 20. Global Oncology (Anti-cancer Drugs) Sales Market Share by Region (2024-2029)
Table 21. Global Oncology (Anti-cancer Drugs) Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2018-2023)
Table 23. Global Oncology (Anti-cancer Drugs) Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2024-2029)
Table 25. North America Oncology (Anti-cancer Drugs) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (K MT)
Table 27. North America Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (K MT)
Table 28. North America Oncology (Anti-cancer Drugs) Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Oncology (Anti-cancer Drugs) Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Oncology (Anti-cancer Drugs) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (K MT)
Table 32. Europe Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (K MT)
Table 33. Europe Oncology (Anti-cancer Drugs) Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Oncology (Anti-cancer Drugs) Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Oncology (Anti-cancer Drugs) Sales by Region (2018-2023) & (K MT)
Table 37. Asia Pacific Oncology (Anti-cancer Drugs) Sales by Region (2024-2029) & (K MT)
Table 38. Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Oncology (Anti-cancer Drugs) Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Oncology (Anti-cancer Drugs) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (K MT)
Table 42. Latin America Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (K MT)
Table 43. Latin America Oncology (Anti-cancer Drugs) Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Oncology (Anti-cancer Drugs) Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Oncology (Anti-cancer Drugs) Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (K MT)
Table 47. Middle East & Africa Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (K MT)
Table 48. Middle East & Africa Oncology (Anti-cancer Drugs) Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Oncology (Anti-cancer Drugs) Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Oncology (Anti-cancer Drugs) Sales (K MT) by Type (2018-2023)
Table 51. Global Oncology (Anti-cancer Drugs) Sales (K MT) by Type (2024-2029)
Table 52. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2018-2023)
Table 53. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type (2024-2029)
Table 54. Global Oncology (Anti-cancer Drugs) Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Oncology (Anti-cancer Drugs) Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2018-2023)
Table 57. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Type (2024-2029)
Table 58. Global Oncology (Anti-cancer Drugs) Price (USD/MT) by Type (2018-2023)
Table 59. Global Oncology (Anti-cancer Drugs) Price (USD/MT) by Type (2024-2029)
Table 60. Global Oncology (Anti-cancer Drugs) Sales (K MT) by Application (2018-2023)
Table 61. Global Oncology (Anti-cancer Drugs) Sales (K MT) by Application (2024-2029)
Table 62. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2018-2023)
Table 63. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application (2024-2029)
Table 64. Global Oncology (Anti-cancer Drugs) Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Oncology (Anti-cancer Drugs) Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2018-2023)
Table 67. Global Oncology (Anti-cancer Drugs) Revenue Market Share by Application (2024-2029)
Table 68. Global Oncology (Anti-cancer Drugs) Price (USD/MT) by Application (2018-2023)
Table 69. Global Oncology (Anti-cancer Drugs) Price (USD/MT) by Application (2024-2029)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 73. Roche Oncology (Anti-cancer Drugs) Product
Table 74. Roche Recent Developments/Updates
Table 75. Novartis Corporation Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 78. Novartis Oncology (Anti-cancer Drugs) Product
Table 79. Novartis Recent Developments/Updates
Table 80. Celgene Corporation Information
Table 81. Celgene Description and Business Overview
Table 82. Celgene Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 83. Celgene Oncology (Anti-cancer Drugs) Product
Table 84. Celgene Recent Developments/Updates
Table 85. Amgen Corporation Information
Table 86. Amgen Description and Business Overview
Table 87. Amgen Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 88. Amgen Oncology (Anti-cancer Drugs) Product
Table 89. Amgen Recent Developments/Updates
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 93. Johnson & Johnson Oncology (Anti-cancer Drugs) Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 98. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product
Table 99. GlaxoSmithKline Recent Developments/Updates
Table 100. Eli lilly & Co Corporation Information
Table 101. Eli lilly & Co Description and Business Overview
Table 102. Eli lilly & Co Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 103. Eli lilly & Co Oncology (Anti-cancer Drugs) Product
Table 104. Eli lilly & Co Recent Developments/Updates
Table 105. Pfizer Corporation Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 108. Pfizer Oncology (Anti-cancer Drugs) Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Merck & Co. Corporation Information
Table 111. Merck & Co. Description and Business Overview
Table 112. Merck & Co. Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 113. Merck & Co. Oncology (Anti-cancer Drugs) Product
Table 114. Merck & Co. Recent Developments/Updates
Table 115. Sanofi Corporation Information
Table 116. Sanofi Description and Business Overview
Table 117. Sanofi Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. Sanofi Oncology (Anti-cancer Drugs) Product
Table 119. Sanofi Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Oncology (Anti-cancer Drugs) Distributors List
Table 123. Oncology (Anti-cancer Drugs) Customers List
Table 124. Oncology (Anti-cancer Drugs) Market Trends
Table 125. Oncology (Anti-cancer Drugs) Market Drivers
Table 126. Oncology (Anti-cancer Drugs) Market Challenges
Table 127. Oncology (Anti-cancer Drugs) Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oncology (Anti-cancer Drugs)
Figure 2. Global Oncology (Anti-cancer Drugs) Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Oncology (Anti-cancer Drugs) Market Share by Type in 2022 & 2029
Figure 4. Blood Cancer Product Picture
Figure 5. Breast Cancer Product Picture
Figure 6. Gastrointestinal Cancer Product Picture
Figure 7. Prostate Cancer Product Picture
Figure 8. Others Product Picture
Figure 9. Global Oncology (Anti-cancer Drugs) Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Oncology (Anti-cancer Drugs) Market Share by Application in 2022 & 2029
Figure 11. Chemotherapy
Figure 12. Targeted Therapy
Figure 13. Immunotherapy (Biologic Therapy)
Figure 14. Hormonal Therapy
Figure 15. Others
Figure 16. Global Oncology (Anti-cancer Drugs) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Oncology (Anti-cancer Drugs) Market Size (2018-2029) & (US$ Million)
Figure 18. Global Oncology (Anti-cancer Drugs) Sales (2018-2029) & (K MT)
Figure 19. Global Oncology (Anti-cancer Drugs) Average Price (USD/MT) & (2018-2029)
Figure 20. Oncology (Anti-cancer Drugs) Report Years Considered
Figure 21. Oncology (Anti-cancer Drugs) Sales Share by Manufacturers in 2022
Figure 22. Global Oncology (Anti-cancer Drugs) Revenue Share by Manufacturers in 2022
Figure 23. The Global 5 and 10 Largest Oncology (Anti-cancer Drugs) Players: Market Share by Revenue in 2022
Figure 24. Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 25. Global Oncology (Anti-cancer Drugs) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 26. North America Oncology (Anti-cancer Drugs) Sales Market Share by Country (2018-2029)
Figure 27. North America Oncology (Anti-cancer Drugs) Revenue Market Share by Country (2018-2029)
Figure 28. U.S. Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe Oncology (Anti-cancer Drugs) Sales Market Share by Country (2018-2029)
Figure 31. Europe Oncology (Anti-cancer Drugs) Revenue Market Share by Country (2018-2029)
Figure 32. Germany Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Oncology (Anti-cancer Drugs) Sales Market Share by Region (2018-2029)
Figure 38. Asia Pacific Oncology (Anti-cancer Drugs) Revenue Market Share by Region (2018-2029)
Figure 39. China Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Taiwan Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Philippines Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Oncology (Anti-cancer Drugs) Sales Market Share by Country (2018-2029)
Figure 50. Latin America Oncology (Anti-cancer Drugs) Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa Oncology (Anti-cancer Drugs) Sales Market Share by Country (2018-2029)
Figure 55. Middle East & Africa Oncology (Anti-cancer Drugs) Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. U.A.E Oncology (Anti-cancer Drugs) Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Sales Market Share of Oncology (Anti-cancer Drugs) by Type (2018-2029)
Figure 60. Global Revenue Market Share of Oncology (Anti-cancer Drugs) by Type (2018-2029)
Figure 61. Global Oncology (Anti-cancer Drugs) Price (USD/MT) by Type (2018-2029)
Figure 62. Global Sales Market Share of Oncology (Anti-cancer Drugs) by Application (2018-2029)
Figure 63. Global Revenue Market Share of Oncology (Anti-cancer Drugs) by Application (2018-2029)
Figure 64. Global Oncology (Anti-cancer Drugs) Price (USD/MT) by Application (2018-2029)
Figure 65. Oncology (Anti-cancer Drugs) Value Chain
Figure 66. Oncology (Anti-cancer Drugs) Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
  • Global Botox for Hyperhidrosis Treatment Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 91
    The global Botox for Hyperhidrosis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Botox for Hyperhidrosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 throug......
  • Global Caffeine Citrate Injection Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 91
    The global Caffeine Citrate Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Caffeine Citrate Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. ......
  • Global Anti-aging Chinese Herbs Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 101
    The global Anti-aging Chinese Herbs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Anti-aging Chinese Herbs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. Asi......
  • Global Medical Nicotine Transdermal Skin Patch Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 103
    The global Medical Nicotine Transdermal Skin Patch market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Medical Nicotine Transdermal Skin Patch is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of......
  • Global Genetically Modified Drug Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 103
    Drugs made by genetically modified means are also called "biological drugs" The global Genetically Modified Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Genetically Modified Drug is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Cyclic Olefin Polymers Syringe Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 93
    Cyclic olefin copolymer (COC) is an amorphous polymer made by several polymer manufacturers. COP (Cyclo-Olefin-Polymer) syringes are distinguished by a high degree of break resistance, glass-like transparency and very low oxygen permeation compared to other plastics. The global Cyclic Olefin Polymers Syringe market was valued at US$ 709 million in 2022 and is anticipated to reach US$ 1065.6 million by 2029, witnessing a CAGR of 6.0% during the forecast period 2023-2029. The influence of C......
  • Global Live and Attenuated Vaccine Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 98
    The global Live and Attenuated Vaccine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Live and Attenuated Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • Global Peripherally Acting Anti-Obesity Drug Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 91
    The global Peripherally Acting Anti-Obesity Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Peripherally Acting Anti-Obesity Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 202......
  • Global Medical Oral Medicine Market Research Report 2023
    Published: 26-May-2023        Price: US 2900 Onwards        Pages: 95
    Oral medical drugs mainly include drugs for treating infections in the oral cavity, throat, periodontal and other parts, and alleviating local pain and irritation in the oral cavity. The global Medical Oral Medicine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs